Search

Author/Creator Raeman, F.

1. OP0180 Remission Induction with Dmard Combinations and Glucocorticoids is not Superior to Remission Induction with MTX Monotherapy and Glucocorticoids: Week 52 Results of the High-Risk Group from the Carera Trial. (9th June 2015)

Authors:
Verschueren, P.; De Cock, D.; Corluy, L.; Joos, R.; Langenaken, C.; Taelman, V.; Raeman, F.; Ravilingien, I.; Vandevyvere, K.; Lenaerts, J.; Geens, E.; Geusens, P.; Vanhoof, J.; Durnez, A.; Remans, J.; Vander Cruyssen, B.; Van Essche, E.; Sileghem, A.; De Brabanter, G.; Joly, J.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 74(2015)Supplement 2
Page Start:
139
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. THU0079 The Association between Patient Reported Outcomes and Clinical Examination in Newly Diagnosed Spondyloarthritis Patients: Results from the Be-Giant Cohort. (10th June 2014)

Authors:
Varkas, G.; Cypers, H.; Van Praet, L.; Carron, P.; Raeman, F.; Gyselbrecht, L.; Devinck, M.; Corluy, L.; Vanneuville, B.; Elewaut, D.; Van den Bosch, F.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 73:Supplement 2(2014)
Page Start:
204
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. THU0117 Low-Risk Patients Also Benefit from Remission Induction Treatment in Early Rheumatoid Arthritis: Week 52 Results from the Carera Trial. (9th June 2015)

Authors:
De Cock, D.; Corluy, L.; Joos, R.; Langenaken, C.; Taelman, V.; Raeman, F.; Ravilingien, I.; Vandevyvere, K.; Lenaerts, J.; Geens, E.; Geusens, P.; Vanhoof, J.; Durnez, A.; Remans, J.; Vander Cruyssen, B.; Van Essche, E.; Sileghem, A.; De Brabanter, G.; Joly, J.; Meyfroidt, S.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 74(2015)Supplement 2
Page Start:
236
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. THU0121 Comparison of MTX Therapy with or without A Moderate Dose Glucocorticoid Bridging Scheme in Early Rheumatoid Arthritis Patients Lacking Classical Poor Prognostic Markers: Week 16 Results from the Randomized Multicenter Carera Trial. (10th June 2014)

Authors:
De Cock, D.; Westhovens, R.; Corluy, L.; Joos, R.; Langenaken, C.; Taelman, V.; Raeman, F.; Ravelingien, I.; Vandevyvere, K.; Lenaerts, J.; Geens, E.; Geusens, P.; Vanhoof, J.; Durnez, A.; Remans, J.; Vander Cruyssen, B.; Van Essche, E.; Sileghem, A.; De Brabanter, G.; Joly, J.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 73:Supplement 2(2014)
Page Start:
220
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. THU0137 Associated with A Glucocorticoid Bridging Scheme, Methotrexate is as Effective Alone as in Combination with Other DMARDS for Early Rheumatoid Arthritis, with Fewer Reported Side Effects: 16 Weeks Remission Induction Data from the Carera Trial. (10th June 2014)

Authors:
Verschueren, P.; De Cock, D.; Corluy, L.; Joos, R.; Langenaken, C.; Taelman, V.; Raeman, F.; Ravelingien, I.; Vandevyvere, K.; Lenaerts, J.; Geens, E.; Geusens, P.; Vanhoof, J.; Durnez, A.; Remans, J.; Vander Cruyssen, B.; Van Essche, E.; Sileghem, A.; De Brabanter, G.; Joly, J.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 73:Supplement 2(2014)
Page Start:
226
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search